Liminal Biosciences (LMNL) Q3 2022 Earnings Call Transcript

Nov. 13, 2022 10:17 PM ETLiminal BioSciences Inc. (LMNL)
SA Transcripts profile picture
SA Transcripts

Liminal Biosciences (NASDAQ:LMNL) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET

Company Participants

Shrinal Inamdar - Investor Relations

Bruce Pritchard - Chief Executive Officer

Nicole Rusaw - Chief Financial Officer


Good day and welcome to the Liminal Biosciences Third Quarter 2022 Results conference call. At this time, I would like to turn the call over to Shrinal. Please go ahead.

Shrinal Inamdar

Thank you, operator. Good morning, ladies and gentlemen. I am the Associate Director of Investor Relations and Communications at Liminal Biosciences, and I’d like to welcome you to our third quarter results conference call. This recorded webcast will be accessible from the Investor Resources page on the Liminal Biosciences website and will be available for replay later on today. For those of you dialing in, you can find a copy of our presentation slides on the webcast section of the website or via the conference call portal.

Moving on to Slide 2, I’d like to remind everyone that we will be making forward-looking statements during today’s webcast, including remarks or current expectations concerning future developments of the pipeline, the properties of our product candidates, the timing of initiation or nature of preclinical and clinical trials and potential therapeutic areas; regulatory plans, financing plans, our ability to resolve the NASDAQ listing deficiency and regain component NASDAQ with listing rules; the successful and timely integration of the new members of the executive leadership teams; and expected benefits to the company, its financial position, the impact of COVID-19 on our business and possible changes in the industry and competitive environment.

Given the ongoing unpredictability of the COVID-19 pandemic for our future operational objectives, we may need to amend guidance on the expected progress or nature of our business going forward with an improved understanding of how the COVID-19

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.